MarketsStocksPHARMAID
PH

Pharmaids Pharmaceuticals Ltd.

NSE: PHARMAIDBSE: 524572Healthcare
Download Research Report7-page PDF
27.49
-0.47%
NSE · auto-updates while market open
Mkt Cap
₹97 Cr
P / E
-
P / B
2.0
ROE
-21.6%
52W High
₹70.00
52W Low
₹25.60
Key Metrics
Market Cap
₹97 Cr
P / E
-
P / B
2.04
EV / EBITDA
-
ROCE
-15.5%
ROE
-21.6%
Debt / Equity
0.44
Book Value
₹13.51
EPS
-
Div Yield
0.0%
Face Value
-
Promoter Holding
33.0%
Revenue · ₹ Cr
4
FY22
0
FY23
15
FY24
19
FY25
28
FY26
Net Profit · ₹ Cr
0
-8
-12
-14
-12
FY22FY23FY24FY25FY26
EPS · ₹ per share
₹0.1
₹-5.8
₹-3.6
FY22FY23FY24
Q1 2026 snapshot
Sales
₹7 Cr
Operating profit
-
OPM
-
Net profit
₹-1 Cr
EPS
-
Scorecard · 7 axes
Quality
Weak
39/100
Valuation
-
Growth
-
Profitability
Bad
-18.6%
Performance
Bad
-53.0%
Entry Point
Strong
39%
Red Flags
Strong
0 flags
Shareholding Pattern
33.0%Promoter
Promoter33.0%
Public67.0%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue4.724.846.78.835.517.28
Net Profit-3.014-4.803-5.315-2.528-2.646-1.085
NPM %-63.9%-99.2%-79.3%-28.6%-48.0%-14.9%
AlertPre-trade